Orange Juice, Hesperidin and Their Role in Vascular Health Benefit

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions
Metabolic SyndromeVascular CompliancePredisposition to Cardiovascular Disease
Interventions
BEHAVIORAL

Beverage consumption

"Volunteers will consume, in random order, daily 330 ml of 1 experimental beverage per period (Orange Juice, Control Beverage, Control Beverage supplemented with hesperidin) for 6 weeks in each period.~At the beginning and the end of each period, exploration will be conducted at fasted state and at post-prandial state after the administration of a high-fat high-sugar meal."

Trial Locations (1)

63000

University Hospital, Clermont Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

UMR 1019, Unité de Nutrition Humaine, INRAE, Auvergne-Rhône Alpes Center

UNKNOWN

collaborator

Department of Beverage Research, Chair of analysis and technology of plant-based foods, Geisenheim University

UNKNOWN

collaborator

European Fruit Juice Association (AIJN)

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT04731987 - Orange Juice, Hesperidin and Their Role in Vascular Health Benefit | Biotech Hunter | Biotech Hunter